OncoHealth Takes on HPV Testing Market with Protein-Based Assay | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – While the buzz around human papillomavirus testing has centered on DNA-based testing, a startup firm is looking to carve out a place in the market with protein-based tests that it says offer a critical advantage over DNA tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.